Delivery Order SPE2DB20D7061-SPE2DB25FSLW1

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,475.67 firm fixed-price delivery order is for the supply of Junel FE 1.5 mg-30 mcg tablets, a contraceptive medication. The contract has an ultimate completion date of January 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,285.66 firm fixed price delivery order contract is for the supply of the contraceptive drug Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,582.93 firm fixed-price delivery order is for the supply of Junel FE 1 mg-20 mcg tablets, a common oral contraceptive medication, with a period of performance through December 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,651.00 firm fixed-price delivery order is for the supply of Junel FE 1.5 mg-30 mcg tablets, a contraceptive medication. The contract has a completion date of September 22, 2023 and was awarded on September 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,122.97, is for the delivery of Junel FE 1 mg-20 mcg tablets, a hormonal contraceptive. The contract is a delivery order with a firm fixed price, and the ultimate completion date is November 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.96 firm fixed-price delivery order is for Junel FE 1 mg-20 mcg tablets, a generic contraceptive medication. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,276.31 firm fixed-price contract covers the delivery of JUNEL FE 1 MG-20 MCG TABLETS, a generic contraceptive product, through November 15, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is valued at $2,116.22 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product, with a period of performance through January 16, 2025. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen also holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,010.47 firm-fixed-price delivery order covers the supply of the generic pharmaceutical product Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $1,753.76, is for the delivery of Junel FE 1.5 mg-30 mcg tablets. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB25FSLW1
    Delivery Order

This contract award, valued at $2,285.28, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Junel FE 1 mg-20 mcg tablets, a contraceptive medication, and does not have a set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/14/25, 10:26 AM